If you’re a current subscriber, log in below. If you would like to subscribe, please click the subscribe tab above.
Please enter your email and we will send your username and password to you.
The News-Courier staff—
WASHINGTON—The U.S. Food and Drug Administration formally granted emergency approval last Friday for the Pfizer coronavirus vaccine, paving the way for widespread distribution of the long-awaited vaccine to sites across the U.S. starting Monday.
The vaccine, which proved effective in 95% of trials, was expected to be distributed first to hospital healthcare personnel and residents and staffs of long-term care facilities.
The vote passed 17-4 as several committee members took issue with the aspect of approving the vaccine for use in 16- and 17-year-olds due to limited evidence while others argued that there was time for more research for this group.
Additional vaccines from Moderna and Johnson & Johnson are expected to be available next year and U.S. health experts are hoping a combination of vaccines will ultimately enable the U.S. to conquer the outbreak.
